Angulo, D.A.; Alexander, B.; Rautemaa-Richardson, R.; Alastruey-Izquierdo, A.; Hoenigl, M.; Ibrahim, A.S.; Ghannoum, M.A.; King, T.R.; Azie, N.E.; Walsh, T.J.
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. J. Fungi 2022, 8, 1121.
https://doi.org/10.3390/jof8111121
AMA Style
Angulo DA, Alexander B, Rautemaa-Richardson R, Alastruey-Izquierdo A, Hoenigl M, Ibrahim AS, Ghannoum MA, King TR, Azie NE, Walsh TJ.
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. Journal of Fungi. 2022; 8(11):1121.
https://doi.org/10.3390/jof8111121
Chicago/Turabian Style
Angulo, David A., Barbara Alexander, Riina Rautemaa-Richardson, Ana Alastruey-Izquierdo, Martin Hoenigl, Ashraf S. Ibrahim, Mahmoud A. Ghannoum, Thomas R. King, Nkechi E. Azie, and Thomas J. Walsh.
2022. "Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections" Journal of Fungi 8, no. 11: 1121.
https://doi.org/10.3390/jof8111121
APA Style
Angulo, D. A., Alexander, B., Rautemaa-Richardson, R., Alastruey-Izquierdo, A., Hoenigl, M., Ibrahim, A. S., Ghannoum, M. A., King, T. R., Azie, N. E., & Walsh, T. J.
(2022). Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. Journal of Fungi, 8(11), 1121.
https://doi.org/10.3390/jof8111121